Neoadjuvant PD-(L)1 Blockade with or Without Chemotherapy Versus Chemotherapy Alone in Mismatch Repair-Deficient, Potentially Resectable Stage III-IVA Gastric Cancer Patients: a Single-Center Retrospective Study
World Journal of Surgical Oncology（2024）
Key words
Neoadjuvant treatment,Gastric cancer,Mismatch repair deficiency,Immune checkpoint blockade,PD-L1
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined